Nov 12, 2019 / 09:30PM GMT
Operator
Good afternoon, everyone, and welcome to Inovio's Third Quarter 2019 Financial Results Conference Call. (Operator Instructions) Please note, today's event is also being recorded.
At this time, I'd like to turn the conference call over to Mr. Ben Matone, Senior Director of Investor Relations. Sir, please go ahead.
Ben Matone - Inovio Pharmaceuticals, Inc. - Director of IR
Thank you, operator. Good afternoon, and thank you for joining the Inovio Pharmaceuticals Third Quarter 2019 Earnings Conference Call. On the call today are Inovio's President and CEO, Dr. J. Joseph Kim; our Chief Financial Officer, Peter Kies; and Dr. Jeffrey Skolnik, Vice President of Clinical Oncology Development.
Today's call is being webcast live on our website, ir.inovio.com, and a replay of today's call will be made available shortly after the call is concluded. Following a general business update, we will conduct a question-and-answer segment, which will be reserved for equity research analysts.
On this call, we will be making forward-looking statements that
Q3 2019 Inovio Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot